1. Cancer Risk
| Metric | Smoking | Vaping | Reduction |
|---|---|---|---|
| IARC-listed carcinogens | 70+ compounds | 9 compounds (trace levels) | ~87% reduction |
| Tar exposure | Yes — primary carcinogen delivery | None — no combustion | 100% elimination |
| Formaldehyde exposure | High (from combustion) | Low (from PG thermal decomposition at high temps) | 90-99% reduction |
| Nitrosamines (TSNAs) | High (tobacco-specific) | Trace (only in tobacco-derived nicotine) | 97-99% reduction |
| Polycyclic aromatic hydrocarbons | High (from combustion) | None | 100% elimination |
Evidence Confidence: Cancer Risk
HIGH Smoking causes cancer — established beyond doubt with millions of cases and decades of epidemiological data.
MODERATE Vaping significantly reduces carcinogen exposure — chemical analysis confirms 87-99% reduction in known carcinogens. However, long-term cancer risk from vaping cannot be fully assessed because vaping has not existed long enough for epidemiological cancer studies (which require 20-30 year latency periods).
Key uncertainty: Whether decades-long inhalation of low-level formaldehyde and flavoring compounds in vape aerosol increases cancer risk above baseline. No confirmed cases of cancer caused solely by vaping exist as of 2026.
2. Cardiovascular Disease
Smoking is a leading cause of cardiovascular disease — heart attacks, strokes, and peripheral artery disease. The mechanisms are well understood: combustion products damage blood vessel linings, promote plaque buildup, increase blood clotting, and reduce oxygen delivery.
| Cardiovascular Factor | Smoking | Vaping | Difference |
|---|---|---|---|
| Carbon monoxide binding | CO binds to 4-15% of hemoglobin | No CO production (no combustion) | Eliminated |
| Endothelial damage | Severe — combustion products directly damage vessel lining | Mild — nicotine causes vasoconstriction; PG/VG aerosol less damaging | Significantly reduced |
| Heart rate increase | +10-20 bpm during and after smoking | +5-10 bpm (nicotine effect only) | ~50% less |
| Blood pressure | Chronic elevation | Transient elevation during use | Significantly reduced |
| Platelet activation (clotting) | Increased — raises heart attack risk | Mild increase from nicotine | Significantly reduced |
Evidence Confidence: Cardiovascular
HIGH Smoking causes cardiovascular disease — established causation.
MODERATE Vaping reduces cardiovascular risk factors — CO is eliminated, endothelial damage is reduced. However, nicotine itself has cardiovascular effects, and the long-term impact of chronic vaping on heart health is not yet fully characterized.
Key study: The VapeScan study (covered in our heart health analysis) found that dual users (vaping + smoking) showed less cardiovascular improvement than exclusive vapers — suggesting that complete switching, not dual use, is necessary for meaningful risk reduction.
3. Respiratory Health
This is where the vaping-vs-smoking comparison gets most nuanced. Smoking destroys lungs through tar deposition, chronic inflammation, and cilia paralysis. Vaping doesn't produce tar, but the aerosol is not inert.
| Respiratory Factor | Smoking | Vaping | Difference |
|---|---|---|---|
| Tar deposition in lungs | Heavy — accumulates over years | None — no combustion | 100% eliminated |
| COPD risk | Leading cause — 80% of COPD cases | No confirmed cases caused solely by vaping | Risk appears minimal |
| Lung cancer risk | Leading cause — 80-90% of cases | No confirmed cases from vaping alone | Risk appears minimal |
| Airway inflammation markers | Severely elevated | 16% of smoker levels (2024 study) | ~84% reduction |
| Cough and phlegm production | Chronic smoker's cough | Mild cough in some users; may improve when switching from smoking | Significantly reduced |
| Bronchial irritation | Chronic | Acute irritation in some users (PG sensitivity) | Reduced but not eliminated |
Evidence Confidence: Respiratory
HIGH Smoking causes COPD, emphysema, and lung cancer.
MODERATE Vaping significantly reduces respiratory risk — no tar, fewer inflammation markers. However, chronic inhalation of PG/VG aerosol and flavoring compounds may cause airway irritation in some individuals.
LOW Long-term effects of decades of vaping on lung function — insufficient data (vaping has not existed long enough).
For a deeper dive on EVALI, COPD, and popcorn lung myth-busting, see our lung health research guide.
4. Reproductive Health
Smoking during pregnancy is one of the most preventable causes of infant mortality and low birth weight. The evidence on vaping during pregnancy is less clear.
| Reproductive Factor | Smoking | Vaping |
|---|---|---|
| Low birth weight | Well-established risk (20-30% increased risk) | Nicotine itself restricts fetal blood flow; full risk profile unknown |
| Preterm delivery | Increased risk (27% higher) | Data limited; nicotine exposure is the primary concern |
| Stillbirth | Increased risk | Insufficient data |
| Sudden Infant Death Syndrome (SIDS) | Increased risk from secondhand smoke | Nicotine exposure risk; secondhand vape less harmful than smoke |
| Fetal brain development | Nicotine disrupts development | Nicotine is present in most e-liquids — same risk from nicotine |
Important: The CDC, FDA, and all major medical organizations advise against vaping during pregnancy. While vaping eliminates combustion-related risks (CO, tar), nicotine itself restricts fetal blood flow and may impair brain development. If you are pregnant and trying to quit smoking, consult your doctor about the safest cessation method. See our mental health and vaping guide for cessation strategies.
5. Immune Function
Smoking suppresses immune function, making smokers more susceptible to respiratory infections, slower wound healing, and reduced vaccine effectiveness. Vaping's impact on immunity is an active area of research.
| Immune Factor | Smoking | Vaping |
|---|---|---|
| Respiratory infection susceptibility | Significantly increased (impaired cilia, damaged macrophages) | Moderate increase (PG aerosol may impair macrophage function) |
| Wound healing | Slowed (nicotine + CO reduce blood flow) | Mildly slowed (nicotine vasoconstriction) |
| Vaccine effectiveness | Reduced immune response to vaccines | Insufficient data — nicotine may affect response |
| Lung macrophage function | Severely impaired | Moderately impaired (flavoring compounds, particularly cinnamaldehyde) |
Evidence Confidence: Immune Function
HIGH Smoking suppresses immune function.
LOW Vaping's long-term immune effects — limited data, active research area.
6. Mental Health and Nicotine Dependence
Both smoking and vaping deliver nicotine, which is addictive. The mental health comparison is complex — nicotine has both cognitive benefits (attention, memory) and risks (dependence, withdrawal, anxiety).
| Mental Health Factor | Smoking | Vaping |
|---|---|---|
| Nicotine addiction | Highly addictive | Highly addictive (salt nic may be more rapidly absorbed) |
| Depression/anxiety association | Strong bidirectional link | Strong bidirectional link (nicotine is the driver) |
| Withdrawal symptoms | Severe (irritability, cravings, anxiety) | Similar severity (nicotine-driven) |
| Cessation and mental health improvement | Quitting = antidepressant-level improvement (BMJ 2024) | Switching from smoking to vaping shows intermediate improvement |
| Ritual/behavioral addiction | Strong (hand-to-mouth, breaks, social) | Strong (and potentially more frequent — devices are always available) |
Key finding: A BMJ study (2024) found that quitting smoking produces antidepressant-level improvements in mental health. Exclusive vaping (having quit smoking) shows intermediate improvement. Dual use (both smoking and vaping) shows the worst mental health outcomes — worse than either smoking or vaping alone. For the full analysis, see our vaping and mental health research guide.
